L-OrnithineL-aspartatesalt with CAS 3230-94-2

What is L-Ornithine L-aspartate salt Cas 3230-94-2

Ornithine aspartate was developed in Germany in the 1960s, and it was first used clinically for the treatment of hangover and hepatic encephalopathy. With the accumulation of clinical application experience, ornithine-aspartate has been more widely used in the treatment of liver diseases, and has achieved accurate results in the treatment of hepatic encephalopathy, drug-induced liver damage, fatty liver, chronic hepatitis and other diseases. The curative effect has been widely recognized by clinicians.

Specification

Analysis Content	Specifications	Analysis Method
Appearance	White or off-white powder or crystalline powder	White crystalline powder
	Chemical reaction:positive	Conforms
Identification	The infrared absorption spectrum is consistent with                                               that of reference	Conforms
Specific optical rotation	+26.5°- +29.0°	+27.7°
PH	5.0-7.0	6.3
Light transmittance(430nm)	≥98.0	98.8%
Chloride	≤300ppm	Conforms
Sulfate	≤200ppm	Conforms
Ammonium	≤400ppm	Conforms
Iron	≤30ppm	Conforms
Loss on Drying	≤7.0%	3.0%
Residue on ignition	≤0.1%	0.03%
Residual solvents	Methanol≤0.3%	0.02%
Heavy metals	≤10ppm	Conforms
Arsenic salt	≤1ppm	Conforms
Related substance	Impurity A:≤0.1%	0.002%
	Arginine:≤0.1%	N.D.
	Fumaric acid:≤0.1%	0.0005%
	Acetic acid:≤0.1%	0.005%
	Other max individual impurity:≤0.1%	0.07%
	Total impurities except for known impurities:≤0.5%	0.16%
Endotoxins	＜0.25EU/mg	Conforms
Assay	98.0%-102.0% calculate on anhydrous basis,contain C5H12N2O2.C4H7NO4	99.4%

Application

25kgs/drum,9tons/20’container

25kgs/bag,20tons/20’container

Related Keywords

OrnithneAspartate; L-Orn-L-Asp;(2S)-2-amino-4-hydroxy-4-keto-butyrate; (2S)-2-amino-4-hydroxy-4-oxobutanoate; (2S)-2-azanyl-4-hydroxy-4-oxo-butanoate; [(4S)-4-amino-5-hydroxy-5-keto-pentyl]ammonium; [(4S)-4-amino-5-hydroxy-5-oxopentyl]azanium; [(4S)-4-azanyl-5-hydroxy-5-oxo-pentyl]azanium